Health Market Sciences Launches Tool to Find and Recruit Physicians for Clinical Trials
Health Market Science, Inc., a leading source of healthcare provider data and analytics solutions in the United States, announced the launch of Clinical Investigators, their latest innovation for clinical site recruitment.
Health Market Science Launches Clinical Investigators(TM)
The Only All-Inclusive Tool That Clinical Recruiters Need to Achieve Their Trial Site Recruitment Goals
KING OF PRUSSIA, Pa., July 17 /PRNewswire/ -- Health Market Science, Inc., a leading source of healthcare provider data and analytics solutions in the United States, announced today the launch of Clinical Investigators, their latest innovation for clinical site recruitment. Clinical Investigators dramatically reduces the time needed by pharmaceutical companies and contract research organizations (CRO's) to recruit physicians for clinical trials by providing instant online access to one of the industry's most comprehensive, up-to-date national databases of physician reference data, clinical trial experience, and claims volume rankings.
"With more than 80% of clinical trials experiencing delays, the industry is looking for insight into how trial site selection can become a more effective, efficient and repeatable process," says Zach Henderson, Vice President, Marketing and Product Development at Health Market Science. "Clinical Investigators provides our clients a competitive advantage by accelerating the identification and recruitment of the best investigators for their trial protocol.
"Clinical operations executives continue to face the increased pressures of heightened regulatory scrutiny of trial results, soaring R&D costs, and the need to accelerate the time-to-market for new drugs. Clinical Investigators allows users to immediately begin their planning for site recruitment or aid them in the implementation of an effective rescue plan to get their trial back on target as well as reduce additional costs and time delays.
Clinical Investigators links an intuitive web-based user interface with a national, comprehensive database of trial experience detail, claims data, and Health Market Science's Provider Master File. With over 4.5 million individual providers and 1.0 million healthcare organizations, the Health Market Science Provider Master File is a trusted source of physician site detail and affiliations.
About Health Market Science
Health Market Science is the leading source for healthcare provider data and advanced analytics in the United States. Health Market Science has developed unique technology and expertise to continuously acquire, analyze, and integrate over 2,500 distinct data sources to create and maintain the single most comprehensive and accurate source of healthcare provider information available today. The HMS MasterFile(TM) includes detailed reference information for over 4.5 million individual providers and 1.0 million healthcare organizations.
Serving all segments of healthcare, including pharmaceutical manufacturers, biotechs, device manufacturers, payers, providers, and pharmacy chains, Health Market Science is the only company that offers claims information, advanced analytics and the reference data that powers them. This unique combination results in dramatically higher data accuracy and reliability, enabling our customers to increase revenues, drive operational efficiencies, achieve regulatory compliance, and maximize market opportunities.
Recognized on the Inc. 500 as one of the fastest growing private companies in the United States and 10th on Deloitte's Technology Fast 50 Program for Greater Philadelphia, our more than 200 customers include 20 of the top 20 pharmaceutical manufacturers, 10 of the 15 largest device manufacturers, and 3 of the top 5 pharmacy chains. Health Market Science is a privately held company located in King of Prussia, PA. For more information, visit www.healthmarketscience.com. For more information on Clinical Investigators go to http://www.healthmarketscience.com/targeting/clinical-investigators.php
SOURCE Health Market Science, Inc.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.
